We offer comprehensive treatments for liver, kidney, pancreas, and islet transplantation. With more than 6000 successful solid organs, bone and marrow transplants, we have established a reputation for excellence and innovation in patient care and research. We are proud to participate in more than 60 research protocols and have trained more than 35 transplant surgeons who are now operating worldwide. Our surgeons provide transplant services at two locations, Baylor University Medical Center, Dallas and Baylor All Saints, Fort Worth.
Antibody Mediated Rejection in Liver Transplantation Symposium
The surgical, medical and pathology leaders in transplantation gathered in Dallas, March 22-23 to participate in a 2 day collaboration to define Antibody Mediated Rejection in Liver Transplantation and forge a path of future research. The program was co-chaired by Goran Klintmalm, MD and Jacqueline O’Leary, MD. (of the Annette C. and Harold C. Transplant Institute) The symposium attracted physicians and clinicians from across the US, Canada, Japan, Belgium, Germany, England, France, Italy, and Australia.
Living Donor Liver Transplantation
First Living Liver Donation In A Decade At Baylor A Success
Our Living Liver Donor Transplant team is led by Dr. Giuliano Testa. Dr. Testa specializes
in living donor liver transplantation for adult patients and is the Surgical Director of Living Donor Liver Transplantation at Baylor University Medical Center. Before joining the Annette C. and Harold C. Simmons Transplant Institute, Dr. Testa was Director of the Living Donor Liver Transplant Program at the University of Illinois and then Director of Liver Transplant and Hepatobiliary Surgery at the University of Chicago. Other members of the Baylor multidisciplinary team for the living liver donor include:
Living Donor Advocate
Living Donor Transplant Coordinator
Dr. Testa has been performing living donor liver transplants for more than a decade. That experience combined with the expertise of the living liver donor transplant team broadens the Simmons Transplant Institute’s services and offers liver transplant patients hope for better outcomes and improved quality of life.
Many of our transplant recipients are approaching their 25-year survival milestones and are leading rich and productive lives.
Baylor Dallas' 3-year liver transplant patient survival rate is an impressive 83.13% which exceeds the expected rate of 78.99%.
Baylor Dallas' 3-year kidney transplant patient survival rate is 94.58% which is above the expected rate of 92.64%.
We attribute this success to Baylor investigators’ participation in developing today’s more effective anti-rejection drugs that are far less toxic than those used in the past.